Testicular Cancer May Raise Prostate Cancer Risk

Share this content:
Men who've had testicular cancer may be at increased risk for prostate cancer, although that risk is low.
Men who've had testicular cancer may be at increased risk for prostate cancer, although that risk is low.

Men who've had testicular cancer may be at increased risk for prostate cancer, although that risk is low, according to a study scheduled to be presented at the American Society of Clinical Oncology's (ASCO) annual Genitourinary Cancers Symposium.

Researchers analyzed data for 179,479 American men and found that 12.6 percent of those with a history of testicular cancer developed prostate cancer by age 80, compared with 2.8 percent of those who never had testicular cancer.

Men who'd had testicular cancer were also more likely to develop intermediate- or high-risk prostate cancer (5.8 versus 1.1 percent).

Overall, testicular cancer was associated with a 4.7 times higher risk for prostate cancer and a 5.2 times higher risk for intermediate- or high-risk prostate cancer, the researchers said.

RELATED: Long-Term Androgen Deprivation Better Than Short-Term in Prostate Cancer

"Men with a history of testicular cancer should talk with their doctor about assessing their risk for prostate cancer, given there may be an increased risk," senior study author Mohummad Minhaj Siddiqui, M.D., an assistant professor of surgery at the University of Maryland School of Medicine in Baltimore, said in an ASCO news release.

It's important to keep in mind that the chance of intermediate- or high-risk prostate cancer is low, and that 95 percent of testicular cancer patients will not get prostate cancer, Siddiqui noted.

"It is too soon to make any practice recommendations based on this single study, but the findings provide groundwork for further research into the biologic link between the two diseases."

Reference

  1. Riggin, Andrew John, et al. "Development of intermediate and high-risk prostate cancer after testicular cancer." 2015 Genitourinary Cancers Symposium. February 26, 2015. Abstract #177.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters